Peptide reference
Tirzepatide
Tirzepatide is an FDA-approved dual GIP/GLP-1 agonist. What it is approved for, and what it is not.
Not yet attributed. This page has no named author or medical reviewer assigned. It must not publish in this state.
Educational only — not medical advice. Nothing here is a recommendation to take, obtain, or self-administer any compound. Talk to a qualified clinician.
At a glance
- FDA status
- FDA-approved
- Class
- GIP/GLP-1 agonist
- Evidence grade
- Strong
- Legal to sell as a supplement
- No
The Tirzepatide reference is not published yet
- — No content file for this route.
The regulatory status above is maintained independently of the article and is current as of its stated review date.
The brief
Get the regulatory brief, every Friday
What changed in peptide regulation, safety and evidence this week. Independent and seller-free.
We sell nothing. Unsubscribe anytime.